Physician profile
Ramesh Ashwath
NPI 1386698074
$8,289.33
in general payments reported to CMS, 2019-2025
38 companies · $791 in 2025
The $791 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,477 · 2020: $330 · 2021: $1,378 · 2022: $1,664 · 2023: $1,474 · 2024: $1,175 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,330 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,329.72 |
| Education | $110.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,672.63 | 2019-2025 | Skyrizi, Rinvoq, Linzess |
| Janssen Biotech, INC. | $661.72 | 2019-2025 | Stelara, Simponi, Simponi Aria |
| Gilead Sciences, INC. | $478.92 | 2019-2025 | |
| Medtronic, INC. | $472.42 | 2021-2024 | Gi Genius, Interstim |
| Janssen Scientific Affairs, LLC | $366.90 | 2022 | |
| Aimmune Therapeutics, INC. | $335.50 | 2024-2025 | Zenpep, Vowst |
| Celgene Corporation | $305.19 | 2021-2024 | Zeposia |
| Pfizer INC. | $292.57 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $242.59 | 2020-2025 | Gattex |
| Ethicon US, LLC | $241.84 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $220.09 | 2021-2023 | |
| Genzyme Corporation | $204.31 | 2022-2025 | |
| Intercept Pharmaceuticals, INC. | $200.45 | 2019-2024 | Ocaliva |
| Boston Scientific Corporation | $191.88 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $188.04 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramesh Ashwath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.